University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Faculty Publications and Other Works -Biomedical and Diagnostic Sciences

Veterinary Medicine -- Faculty Publications and
Other Works

11-5-2014

Chronic Exposure to Combined Carcinogens Enhances Breast Cell
Carcinogenesis with Mesenchymal and Stem-Like Cell Properties
Lenora Ann Pluchino
University of Tennessee, Knoxville

Hwa-Chain Robert Wang
University of Tennessee, Knoxville, hcrwang@utk.edu

Follow this and additional works at: https://trace.tennessee.edu/utk_compmedpubs

Recommended Citation
Pluchino LA, Wang H-CR (2014) Chronic Exposure to Combined Carcinogens Enhances Breast Cell
Carcinogenesis with Mesenchymal and Stem-Like Cell Properties. PLOS ONE 9(11): e108698.
doi:10.1371/journal.pone.0108698

This Article is brought to you for free and open access by the Veterinary Medicine -- Faculty Publications and Other
Works at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Faculty
Publications and Other Works -- Biomedical and Diagnostic Sciences by an authorized administrator of TRACE:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.

Chronic Exposure to Combined Carcinogens Enhances
Breast Cell Carcinogenesis with Mesenchymal and StemLike Cell Properties
Lenora Ann Pluchino1,2, Hwa-Chain Robert Wang1,2*
1 Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, United States of America, 2 Graduate
School of Genome Science and Technology, University of Tennessee, Knoxville, Tennessee, United States of America

Abstract
Breast cancer is the most common type of cancer affecting women in North America and Europe. More than 85% of breast
cancers are sporadic and attributable to long-term exposure to small quantities of multiple carcinogens. To understand how
multiple carcinogens act together to induce cellular carcinogenesis, we studied the activity of environmental carcinogens 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene (B[a]P), and dietary carcinogen 2-amino-1-methyl6-phenylimidazo[4,5-b]pyridine (PhIP) using our breast cell carcinogenesis model. Our study revealed, for the first time, that
combined NNK and B[a]P enhanced breast cell carcinogenesis chronically induced by PhIP in both non-cancerous and
cancerous breast cells. Co-exposure was more potent than sequential exposure to combined NNK and B[a]P followed by
PhIP in inducing carcinogenesis. Initiation of carcinogenesis was measured by transient endpoints induced in a single
exposure, while progression of carcinogenesis was measured by acquisition of constitutive endpoints in cumulative
exposures. Transient endpoints included DNA damage, Ras-Erk-Nox pathway activation, reactive oxygen species elevation,
and increased cellular proliferation. Constitutive endpoints included various cancer-associated properties and signaling
modulators, as well as enrichment of cancer stem-like cell population and activation of the epithelial-to-mesenchymal
transition program. Using transient and constitutive endpoints as targets, we detected that a combination of the green tea
catechins ECG and EGCG, at non-cytotoxic levels, was more effective than individual agents in intervention of cellular
carcinogenesis induced by combined NNK, B[a]P, and PhIP. Thus, use of combined ECG and EGCG should be seriously
considered for early intervention of breast cell carcinogenesis associated with long-term exposure to environmental and
dietary carcinogens.
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microgram levels results in systemic exposure at low nanomolar
levels [8,9]. Gastric administration of PhIP induces mammary
tumors in rats [10,11], and epidemiological studies have indicated
a close association between well-done meat consumption and
human breast cancer risk [12–14]. NNK, a tobacco-specific
nitrosamine ketone, can be detected at picomolar concentrations
in body fluids of tobacco users [15–17]. Although gastric
administration of NNK into rats resulted in DNA adducts and
tumor development in the mammary gland [18,19], NNK is not
yet recognized as a mammary carcinogen. The link between
smoking and breast cancer is controversial; however, recent studies
indicate that exposure to tobacco smoke can increase breast cancer
risk, especially in post-menopausal women [20–22]. Thus, the role
of tobacco carcinogens in breast cancer needs to be clarified.
B[a]P, on the other hand, is recognized as a weak mammary
carcinogen. B[a]P is a polycyclic aromatic hydrocarbon present in
carbon exhaust, charcoal-barbequed foods, and tobacco smoke; it
can be found in picomolar concentrations in human fat and liver
[23–28].

Introduction
Breast cancer is the most common type of cancer and second
leading cause of cancer-related death among women in North
America and Europe [1,2]. Over 85% of breast cancers occur
sporadically due to long-term exposure to low doses of multiple
carcinogens [3–7]. Thus, it is important to investigate how
multiple carcinogens act together to induce cellular carcinogenesis.
We have developed a cellular model that mimics breast cell
carcinogenesis induced by cumulative exposures to physiologically-achievable doses of environmental and dietary carcinogens to
understand the cellular, biochemical, and molecular changes
involved in cellular carcinogenesis for the purposes of intervention.
American lifestyles involve frequent consumption of hightemperature cooked meats containing carcinogens, such as 2amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), and wide
exposures to smoke and polluted air containing 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene
(B[a]P). PhIP is the most abundant heterocyclic amine found in
meat cooked at high temperatures, and consumption of PhIP at
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Our studies have shown that NNK at100 pmol/L, B[a]P at
100 pmol/L, and PhIP at 10 nmol/L are able to induce initiation
and progression of breast cell carcinogenesis [29–35]. A single
exposure to these carcinogens induces transient changes, which
play essential roles in induction of carcinogenesis and can be used
as transient endpoints to promptly reveal carcinogenic activity.
Cumulative exposures to carcinogens progressively induce cellular
acquisition of various cancer-associated properties and activation
of associated pathways; these properties are measurable constitutive endpoints used to determine the progression of cellular
carcinogenesis from non-cancerous to pre-cancerous and cancerous stages [29–35]. Our model also reveals increases of cancer
stem-like cell populations and activation of the epithelial-tomesenchymal transition (EMT) program during carcinogeninduced cellular carcinogenesis [35,36]. Development of cancer
stem-like cells, involving induction of the EMT program, plays
important roles in generating and maintaining pre-malignant and
malignant lesions [37]. Thus, we also used increased cancer stemlike cell population and induced EMT program as constitutive
endpoints in our studies. We then used these endpoints as targets
to identify preventive agents, such as green tea catechins (GTCs)
epicatechin (EC), epicatechin-3-gallate (ECG), epigallocatechin
(EGC), and epigallocatechin-3-gallate (EGCG), at non-cytotoxic
levels, capable of intervening in breast cell carcinogenesis induced
by NNK, B[a]P, or PhIP [31–36].
In this communication, we report the potency of co-exposure
versus pre-exposure of combined NNK and B[a]P (NB) with PhIP
in chronic induction of breast cell carcinogenesis. Co-exposure to
NB and PhIP (NBP) induced higher levels of transient and
constitutive endpoints than pre-exposure to NB followed by PhIP.
We also studied the activity of ECG and EGCG, at non-cytotoxic
levels, in suppression of NBP-induced endpoints. We determined
that a combination of ECG and EGCG was more effective than
either agent alone, at equivalent doses, in intervention of NBPinduced cellular carcinogenesis.

DNA Damage
DNA damage was detected with a comet assay [38]. A total of
26104 cells in ice-cold phosphate-buffered saline (PBS) were
mixed with 1% low-melting agarose (Fisher, Fair Lawn, NJ) and
placed on agarose-coated slides. Slides were immersed in lysis
solution, electrophoresed, stained with propidium iodide and
examined with a fluorescence microscope (Carl Zeiss Inc.,
Thornwood, NY) as described previously [34,35]. Fifty nuclei
per slide were scored for tail moment (% of DNA in the tail X tail
length) using CometScore software (Tritek, Sumerduck, VA).

Reduced dependence on growth factors
A total of 5 6103 cells were seeded in 60-mm culture dishes and
maintained in low-mitogen (LM) medium (1:1 mixture of
DMEM/F12, 2 ng/mL cholera enterotoxin, 200 ng/mL insulin,
10 ng/mL hydrocortisol, 0.4 ng/mL epidermal growth factor, and
0.1% horse serum), containing reduced total serum and mitogenic
additives to 2% of the concentration formulated in CM medium,
for 10 days to develop cell colonies [32–35].

Anchorage-independent growth
A total of 16104 cells were mixed with soft agar consisting of
0.4% low-melting agarose (Sigma-Aldrich) in a mixture (1:1) of
CM medium with 3-day conditioned medium prepared from
MCF10A cultures, plated on top of a 2% low-melting agarose base
layer in 60-mm culture dishes and maintained for 14 days to
develop cell clones [32–35].

Measurement of intracellular ROS
Cells were incubated with 5 mmol/L CM-H2DCF-DA for 1 h
to detect ROS by flow cytometry as described previously [32–35].
Mean fluorescence intensity of dichlorodihydrofluorescein (DCF)
was quantified using Multicycle software (Phoenix Flow System,
San Diego, CA).

Cellular proliferation

Materials and Methods

Cellular proliferation was determined using the 5-bromo-2deoxyuridine (BrdU) cell proliferation enzyme-linked immunosorbent assay (ELISA) kit (Roche, Indianapolis, IN); BrdU-labeled
cells were quantified using an ELISA reader (Bio-Tek, Winooski,
VT), as performed previously [32–35].

Cell cultures and reagents
MCF10A (American Type Culture Collection [ATCC], Rockville, MD) and derived cell lines were maintained in complete
(CM) medium (1:1 mixture of DMEM and HAM’s F12,
supplemented with 100 ng/mL cholera enterotoxin, 10 mg/mL
insulin, 0.5 mg/mL hydrocortisol, 20 ng/mL epidermal growth
factor, and 5% horse serum) [29–36]. Human breast cancer
MCF7 cells (ATCC) were maintained in DMEM supplemented
with 10% heat-inactivated fetal calf serum [34,35]. All cultures
were supplemented with 100 U/mL penicillin and 100 mg/mL
streptomycin and maintained in 5% CO2 at 37uC. Stock solutions
of NNK (Chemsyn, Lenexa, KS), B[a]P (Aldrich, Milwaukee, WI),
PhIP (Midwest; NCI Chemical Carcinogen Reference Standard
Repository), U0126 (Cell Signaling, Beverly, MA), and CMH2DCF-DA (Invitrogen, Carlsbad, CA) were prepared in DMSO;
ECG, EGCG (Sigma-Aldrich, St. Louis, MO), and N-acetyl-Lcysteine (NAC) (Alexis, San Diego, CA) were prepared in distilled
water. All were diluted in CM medium for assays.

Reverse transcription PCR
Total RNA isolated from cultures using the Absolutely RNA kit
(Stratagene, La Jolla, CA) was reverse transcribed to complementary DNA using the Verso cDNA Kit (Thermo Scientific,
Waltham, MA). cDNAs were subjected to PCR for H-Ras
(forward: 59-GACGGAATATAAGCTGGTGG-39; reverse: 59AGGCACGTCTCCCCATCAAT-39) and b-actin (forward: 59GGACTTCGAGCAAGAGATGG-39;
reverse:
59-AGCACTGTGTTGGCGTACG-39). PCR products were electrophoresed on agarose gels and visualized using ethidium bromide
staining.

Immunoblotting
Cell lysates were resolved by electrophoresis in 10% or 12%
SDS–polyacrylamide gels and transferred to nitrocellulose filters
for immunoblotting, as described previously [32–35], with
antibodies specific to H-Ras, phosphorylated Erk1/2 (p-Erk1/2),
Erk1/2, Nox-1, EpCAM, E-cadherin, MMP-9, Vimentin, and bactin (Santa Cruz Biotechnology, Santa Cruz, CA). Antigenantibody complexes were detected by Supersignal West Dura
chemiluminescence kit (Pierce, Rockford, IL).

Chronic induction of cellular carcinogenesis
Twenty-four h after each subculturing, human breast cells were
treated with the indicated carcinogens for 48 h as one cycle of
exposure for 20 cycles. Cells were subcultured every 3 days [29–
36].
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induced a significantly higher level of DNA damage than either
NB or PhIP (Figure 1A). Blockage of the ERK pathway (with the
Mek-specific inhibitor U0126) or ROS production (with the
general antioxidant NAC) significantly reduced NB-, PhIP-, and
NBP-induced DNA damage (Figure 1A). These results indicate
that co-exposure to NB and PhIP was more potent than either was
alone to induce DNA damage for induction of cellular carcinogenesis, and the ERK pathway and ROS production are required
for this process.
To verify whether cumulative exposures to NB and PhIP would
result in enhanced cellular carcinogenesis, we exposed MCF10A
cells to NB, PhIP, and NBP for 20 cycles, resulting in the NB20,
P20, and NBP20 cell lines, respectively. NB20 cells were then
exposed to PhIP for an additional 20 cycles, resulting in the
NB20/P20 cell line. We then compared the potency of these
resulting cell lines by measuring degrees of acquired cancerassociated properties/constitutive endpoints [29–35]. Growth
factors and cellular adhesion to the extracellular matrix are
required for normal epithelial cell survival; in contrast, cancerous
cells acquire a reduced dependence on growth factors (RDGF) and
anchorage-independent growth (AIG) to increase survivability
[37]. Increased ROS production and cellular proliferation are also
closely associated with cellular transformation [37]. We detected
that NB20/P20 and NBP20 cells acquired higher degrees of
RDGF (Figure 1B-1), AIG (B-2), ROS content (B-3), and cellular
proliferation (B-4) than NB20 or P20 cells. NBP20 cells acquired
higher degrees of these endpoints than NB20/P20 cells, reaching
levels comparable to malignant control MCF10A-Ras cells, in
which oncogenic H-Ras is ectopically expressed in MCF10A cells
[39]. The results indicate that pre-exposure (NB20/P20) or coexposure (NBP20) to NB significantly enhanced PhIP-induced
constitutive endpoints, with co-exposure being the most potent.
Our previous studies showed that up-regulated H-Ras gene
expression, as a constitutive molecular endpoint, and activated
Ras-Erk-Nox pathway, as a constitutive biochemical endpoint, are
essential for maintaining constitutive cellular endpoints induced by
PhIP [35]. In studying if these molecular and biochemical changes
were enhanced by NBP, we detected that cumulative pre- and coexposures to NB and PhIP resulted in highly up-regulated H-Ras
gene expression (Figure 1B-5), increased H-Ras protein level, and
activated downstream Erk-Nox pathway (1B-6) in NB20/P20 and
NBP20 cells; these endpoints were up-regulated to higher levels in
NBP20 cells than in NB20/P20 cells but did not reach their
counterpart levels in MCF10A-Ras cells. These results indicate
that NNK and B[a]P can enhance the ability of PhIP to induce
breast epithelial cell carcinogenesis, even though NNK is not
considered a mammary carcinogen, and B[a]P is considered a
weak mammary carcinogen. Co-exposure to these carcinogens is
more potent than pre-exposure to induce cellular acquisition of
cancer-associated properties. The constitutive biochemical endpoints of Ras-Erk-Nox pathway activation and ROS elevation
were induced consistently with constitutive cellular endpoints and
may play important roles in maintaining cancer-associated
properties in NBP-exposed cells.
To verify roles the Erk pathway and ROS may play in NBPexposed cells, we used U0126 to inhibit Mek and NAC to inhibit
ROS in NB20/P20 and NBP20 cells. Treatment with U0126 did
not affect H-Ras expression but reduced Erk activity, Nox-1
expression (Figure 1C-1), ROS level (1C-2), and cell proliferation
(1C-3), indicating that the Erk-Nox pathway plays an important
role in maintaining ROS production and cell proliferation in both
NB20/P20 and NBP20 cells. NAC treatment suppressed the RasErk-Nox pathway (Figure 1C-1), ROS level (1C-2), and cell
proliferation (1C-3), indicating an essential role for ROS

Serum-independent non-adherent growth
A total of 16104 cells were seeded on top of 1% agarose-coated,
non-adherent 100-mm culture plates, incubated in serum-free CM
supplemented with 0.4% bovine serum albumin and maintained
for 10 days to develop mammospheres [35,36].

Aldehyde dehydrogenase (ALDH) assay
An ALDEFLUOR Kit (StemCell Technologies, Durham, NC)
was used to detect ALDH-positive cells. A total of 16105 cells were
mixed with activated Aldefluor substrate BODIPY-aminoacetaldehyde (BAAA) and incubated in the presence and absence of the
ALDH inhibitor diethylaminobenzaldehyde (DEAB), followed by
flow cytometric analysis as described previously [35,36]. Mean
fluorescence intensity of cells was quantified using Multicycle
software (Phoenix Flow System, San Diego, CA). Cells incubated
with BAAA in the presence of DEAB were used to establish
baseline fluorescence for determining the ALDH-positive cell
population in which ALDH activity was not inhibited by DEAB.

In vitro cell invasion and migration
The cell invasion assay was performed using 24-well transwell
insert chambers with a polycarbonate filter with a pore size of
8.0 mm (Costar, Corning, NY). A total of 26104 cells in serum-free
medium were seeded on top of a Matrigel-coated filter (BD
Biosciences, Franklin Lakes, NJ) in each insert chamber. Then, the
insert chambers were placed into wells on top of culture medium
containing 10% horse serum as a chemoattractant. The migration
assay was performed using 24-well transwell insert chambers with
a polycarbonate filter without Matrigel. The invasive or migratory
ability of cells was determined by the number of cells translocated
to the lower side of filters [35,36].

Cell motility wound-healing assay
Cells were seeded in 6-well plates and grown to confluence in
CM medium. Cells were rinsed with PBS and serum-starved for
15 h in DMEM/Ham’s F12 medium containing 2% horse serum.
The monolayer was then scratched with a 23-gauge needle (BD
Biosciences) to generate wounds, rinsed with CM medium to
remove floating cells, and maintained in CM medium. The
wounded areas were examined 6, 12, and 24 h after scratches to
detect healing. The area not healed by the cells was subtracted
from the total area of the initial wound to calculate the wound
healing area using Total Lab TL100 software (Total Lab,
Newcastle, NE).

Statistical analysis
The Student t test was used to analyze statistical significance,
indicated by * P,0.05, ** P,0.01, and *** P,0.001; a P value ,
0.05 was considered significant.

Results and Discussion
Enhanced cellular acquisition of cancer-associated
properties by combined carcinogens
Previous studies have shown that NNK and B[a]P exhibit
comparable abilities to induce breast cell carcinogenesis [33,34].
Combining NNK and B[a]P (NB) additively increases degrees of
all acquired constitutive cellular endpoints except tumorigenicity
[33,34], indicating that NNK and B[a]P may act as weak breast
carcinogens. We first used a comet assay to measure the ability of
these carcinogens to induce cellular DNA damage after one
exposure, which is essential for the induction of cellular
carcinogenesis [37]. Exposure to combined NB and PhIP (NBP)
PLOS ONE | www.plosone.org
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Figure 1. Enhanced cellular acquisition of cancer-associated properties by combined carcinogens. (A) MCF10A cells were treated with
combined 100 pmol/L NNK and 100 pmol/L B[a]P (NB), 10 nmol/L PhIP (P), or combined NB and PhIP (NBP) in the absence and presence of 10 mmol/L
U0126 (U0) or 5 mmol/L NAC for 24 h. DNA damage was measured by a comet assay and normalized by the value of average tail moment
determined in untreated counterpart cells, set as 1 (X, arbitrary unit). Representative images detected in the comet assay are shown. (B-1 to B-6)
MCF10A (10A) cells were repeatedly exposed to NB, PhIP, or NBP for 20 cycles, resulting in the NB20, P20, and NBP20 cell lines, respectively. NB20 cells
were then exposed to PhIP for an additional 20 cycles resulting in the NB20/P20 cell line. MCF10A-Ras (Ras) cells were used as a malignant control. (C1 to C-3) NB20/P20 and NBP20 cells were treated with 10 mmol/L U0 or 5 mmol/L NAC for 48 h. (B-1) To determine cellular acquisition of RDGF, cells
were maintained in LM medium for 10 days. Cell colonies $0.5 mm diameter were counted. (B-2) To determine cellular acquisition of AIG, cells were
seeded in soft agar for 14 days. Cell colonies $0.1 mm diameter were counted. (B-3 and C-2) Relative level of ROS as fold induction (X, arbitrary unit)
was normalized by the level determined in untreated cells, set as 1. (B-4 and C-3) Relative cell proliferation was determined and normalized by the
value of BrdU detected in untreated cells, set as 100%. (B-5) Total RNA was isolated and analyzed by RT-PCR with specific primers to determine
relative gene expression levels of H-Ras, with b-actin as a control, and these levels were quantified by densitometry. (B-6 and C-1) Cell lysates were
analyzed by immunoblotting using specific antibodies to detect levels of H-Ras, phosphorylated-Erk1/2 (p-Erk1/2), Erk1/2, and Nox-1, with b-actin as a
control, and these levels were quantified by densitometry. The levels of H-Ras (Ras/actin) and Nox-1 (Nox/actin) were calculated by normalizing with
the level of b-actin and the level set in untreated control cells as 1 (X, arbitrary unit). Levels of specific phosphorylation of Erk1/2 (p/Erk) were
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calculated by normalizing the levels of p-Erk1/2 with the levels of Erk1/2, then the level set in control cells as 1 (X, arbitrary unit). Columns, mean of
triplicates; bars, SD. All results are representative of three independent experiments. Statistical significance is indicated by * P,0.05, ** P,0.01, and
*** P,0.001.
doi:10.1371/journal.pone.0108698.g001

production in maintaining activated Ras-Erk-Nox pathway and
increased cell proliferation. The results reveal a cross-talk between
the Ras-Erk-Nox pathway and ROS production, which are
necessary for maintaining increased cell proliferation, and possibly
other cancer-associated properties, in NBP-exposed cells.

NBP enhanced cancer-associated properties in breast
cancer MCF7 cells
To clarify whether the enhanced acquisition of cancerassociated properties induced by NBP was limited to estrogen
receptor (ER)-negative MCF10A cells, we exposed ER-positive
human breast cancer MCF7 cells to NBP, NB, and PhIP. A single
exposure to NBP induced more DNA damage in MCF7 cells than
either NB or PhIP (Figure 3A), indicating NBP is more potent
than either NB or PhIP alone to induce DNA damage for cellular
carcinogenesis, even in cancer cells. After five cycles of carcinogen
exposure, we detected significantly increased degrees of the
cancer-associated properties of RDGF (Figure 3B-1), AIG (3B-2),
cell migration (3B-3), and invasion (3B-4) acquired by carcinogenexposed MCF7 cells versus parental cells. Although parental
MCF7 cells possessed levels of these cancer-associated properties
comparable to levels in NBP20 and MCF10A-Ras cells, these
properties were significantly increased by NBP exposure, indicating that cumulative exposures to NBP may increase the potency of
already cancerous cells. NBP was more potent than NB or PhIP in
MCF7 cells, which is consistent with results seen in MCF10A cells.
We next investigated if cumulative exposures to NBP, NB, and
PhIP also resulted in induction of the biochemical endpoints of
ROS elevation and Ras-Erk-Nox pathway activation in MCF7
cells as they did in MCF10A cells. We detected that parental
MCF7 cells possessed higher levels of ROS (Figure 3B-5), H-Ras
protein expression, Erk activation, and Nox-1 protein expression
(3B-6) than MCF10A cells, and cumulative exposures to NBP were
able to furthermore increase ROS production and Ras-Erk-Nox
pathway induction in MCF7 cells. Exposure to NBP resulted in
higher levels of ROS production (Figure 3B-5) and Ras-Erk-Nox
pathway induction (3B-6) in MCF7 cells than either NB or PhIP
alone, consistent with the higher levels of cancer-associated
properties (3B-1 to B-4) acquired by NBP-exposed versus NB- or
PhIP-exposed MCF7 cells. These results indicated that cumulative
exposures to combined NNK, B[a]P, and PhIP were able to
constitutively induce cellular acquisition of cancer-associated
properties and associated biochemical endpoints in not only
non-cancerous ER-negative MCF10A cells, but also cancerous
ER-positive MCF7 cells in a similar manner. A combination of
multiple carcinogens was more potent than individual carcinogens
in long-term induction of breast cell carcinogenesis progression in
both non-cancerous and cancerous cells in an ER-independent
manner. Thus, co-exposure to low doses of NNK, B[a]P, and PhIP
should be seriously considered in epidemiological studies to reveal
the value of these carcinogens in the development of sporadic
breast cancer. Given their ability to increase cancer-associated
properties in non-cancerous or cancerous cells alike, it is important
to identify agents capable of blocking breast cell carcinogenesis
induced by cumulative exposures to combined carcinogens for
early intervention of this disease.

Enhanced acquisition of stem-like and mesenchymal cell
properties by combined carcinogens
Mammary stem-like cells are able to self-renew in serum-free
media, are known to exhibit high levels of ALDH activity, and
have a unique ability to form discrete spheroid clusters called
mammospheres in non-adherent cultures [40,41]. We have
reported that enrichment of ALDH-positive cell populations and
increased formation of mammospheres were induced by cumulative exposures to NB [36] or PhIP [35] in MCF10A cells.
However, increased stem-like cell population is not yet fully
appreciated as a breast cancer-associated property. Growth of
mammospheres (serum-independent non-adherent growth, SINAG) involves the properties of RDGF and AIG, both of which
are enhanced by NBP exposure. Thus, it was important to
understand whether NBP-enhanced cellular carcinogenesis was
accompanied by enhanced stem-like cell properties. As shown in
Figure 2, mammospheres (2A) and ALDH-positive cell population
(2B) were increasingly induced in NB20, P20, NB20/P20, and
NBP20 cells (NB20,P20, NB20/P20, NBP20). Accordingly,
cumulative co-exposures of cells to NBP resulted in acquisition of
significantly increased stem-like cell populations that should be
considered a novel cancer-associated property used to measure the
progression of breast cell carcinogenesis.
The ability to develop stem-like cells is associated with
activation of the EMT program [37]. During EMT, reduction of
epithelial cellular adhesion molecule (EpCAM) and E-cadherin is
associated with a loss in cell-cell adhesion [42] while an increase in
matrix metalloproteinase-9 (MMP-9) is involved in degradation of
the extracellular matrix [37]; increased Vimentin plays a role in
filament formation and cell motility [43]. We detected that
EpCAM and E-cadherin were reduced but MMP-9 and Vimentin
were increased (Figure 2C) in NB- and/or PhIP-exposed cells, and
these changes occurred consistently with degrees of increased
mammosphere formation (2A) and enriched ALDH-positive stemlike cell populations (2B). Induction of the EMT program has been
postulated to not only contribute to cellular acquisition of stem-like
properties but also increased migratory and invasive capabilities
[37]. We detected that increased degrees of cell migration
(Figure 2D) and invasion (2E) were closely correlated with the
increased degrees of mammosphere formation (2A), stem-like cell
population (2B), and EMT markers (2C) acquired by NB- and/or
PhIP-exposed cells: NBP20. NB20/P20.P20. NB20. In
addition, using a wound healing assay, we detected that increased
cell motility (Figure 2F-1 and 2F-2) was also accordingly acquired
by these NB- and/or PhIP-exposed cells. These results indicate
that cumulative exposure to NBP significantly enhanced cellular
acquisition of stem-like and EMT-associated markers and
properties. Cellular acquisition of stem-like and EMT-associated
properties should be considered as novel cancer-associated
properties and constitutive endpoints in measurement of the
progression of breast cell carcinogenesis.

PLOS ONE | www.plosone.org

Intervention of NBP-induced carcinogenesis
In our previous reports, we demonstrated that GTCs, at noncytotoxic levels, were capable of suppressing breast cell carcinogenesis induced by NB or PhIP [33–35]. EGCG, the major
catechin present in green tea extract, is the most commonly
studied preventive GTC [44], but some studies have shown that
ECG may be more effective than EGCG in intervention of
carcinogenesis [34,45,46]. ECG and EGCG have similar molec5
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Figure 2. Enhanced acquisition of mesenchymal and stem-like cell properties by combined carcinogens. (A) To determine cellular
acquisition of the ability of serum-independent non-adherent growth (SINAG), MCF10A (10A), NB20, P20, NB20/P20, NBP20, and MCF10A-Ras (Ras)
cells were seeded in non-adherent cultures for 10 days; then, mammospheres ($0.1 mm diameter) were counted. (B) Mammospheres were collected
and trypsinized, and ALDH-expressing (ALDH+) cell population (%) was measured by flow cytometry. (C) Cell lysates were analyzed by
immunoblotting using specific antibodies to detect levels of EpCAM, E-cadherin, MMP-9 and Vimentin, with b-actin as a control, and these levels were
quantified by densitometry. The levels of EpCAM, E-cadherin, MMP-9, and Vimentin were calculated by normalizing with the level of b-actin and the
level set in untreated control cells as 1 (X, arbitrary unit). (D) Cellular migratory and (E) invasive activities were determined by counting the numbers
of cells translocated through a polycarbonate filter without or with coated Matrigel, respectively, in 10 arbitrary visual fields. (F-1) Cellular acquisition
of increased motility was determined by wound healing assay. The wounded areas were examined (magnification, 1006) 6, 12, and 24 h afterward.
Arrows indicate width of wounded areas. (F-2) To quantitatively measure cell motility detected in F-1, the area not healed by the cells was subtracted
from the total area of the initial wound to calculate the wound healing area (%) at intervals of 6 (white columns) and 12 h (gray columns). Columns,
mean of triplicates; bars, SD. All results are representative of three independent experiments. Statistical significance is indicated by * P,0.05, ** P,
0.01, and *** P,0.001.
doi:10.1371/journal.pone.0108698.g002
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Figure 3. NBP-enhanced cancer-associated properties in breast cancer MCF7 cells. (A) MCF10A cells (10A) were treated with NBP, and
MCF7 cells were treated with NBP, NB, or PhIP (P) for 24 h. DNA damage was measured by a comet assay and normalized by the value of average tail
moment determined in untreated counterpart cells, set as 1 (X, arbitrary unit). (B-1 to B-6) MCF7 cells were exposed to NBP, NB, or PhIP for five cycles
(NBP5, NB5, and P5). The NBP20 and MCF10A-Ras (Ras) cell lines were used as comparisons. (B-1) To determine cellular acquisition of RDGF, cells were
maintained in LM medium for 10 days. Cell colonies $0.5 mm diameter were counted. (B-2) To determine cellular acquisition of AIG, cells were
seeded in soft agar for 14 days. Cell colonies $0.1 mm diameter were counted. Cellular migratory (B-3) and invasive (B-4) activities were determined
by counting the numbers of cells translocated through a polycarbonate filter without or with coated Matrigel, respectively, in 10 arbitrary visual fields.
(B-5) Relative level of ROS as fold induction (X, arbitrary unit) was normalized by the level determined in untreated cells, set as 1. (B-6) Cell lysates
were analyzed by immunoblotting using specific antibodies to detect levels of H-Ras, p-Erk1/2, Erk1/2, and Nox-1, with b-actin as a control, and these
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levels were quantified by densitometry. Levels of H-Ras (Ras/actin) and Nox-1 (Nox/actin) were calculated by normalizing with the level of b-actin and
the level set in untreated control cells as 1 (X, arbitrary unit). Levels of specific phosphorylation of Erk1/2 (p/Erk) were calculated by normalizing the
levels of p-Erk1/2 with the levels of Erk1/2, then the level set in control cells as 1 (X, arbitrary unit). Columns, mean of triplicates; bars, SD. All results
are representative of three independent experiments. Statistical significance is indicated by * P,0.05, ** P,0.01, and *** P,0.001.
doi:10.1371/journal.pone.0108698.g003

ular masses, 442.37 and 458.37 g/mol, respectively. Our previous
studies revealed that both ECG and EGCG at 40 mg/mL are toxic
to MCF10A cells [34]. However, at a non-cytotoxic dose of
10 mg/mL, ECG is more effective than EGCG in suppression of
NB-induced cellular carcinogenesis [34]. ECG at 10 mg/mL and
EGCG at 5 mg/mL show comparable effectiveness in suppression
of PhIP-induced cellular carcinogenesis [35]. Thus, to address
whether ECG, EGCG, or a combination of both would be most
effective in suppressing NBP-induced cellular carcinogenesis, we
initially studied the effectiveness of ECG and EGCG, at noncytotoxic doses, in blocking transient endpoints induced by a single
exposure to NBP and subsequently verified their ability to suppress
NBP-induced constitutive endpoints after cumulative exposures.
As shown in Figure 4, both ECG (E) and EGCG (G), at 10 or
20 mg/mL, were able to block NBP-induced transient endpoints of
ROS elevation (4A-1) and DNA damage (4A-2), with ECG being
more effective than EGCG in suppressing these properties.
Interestingly, a combination of ECG and EGCG (E+G) at 5 or
10 mg/mL each was more effective than individual catechins at 10
or 20 mg/mL, respectively, in suppression of NBP-induced ROS
and DNA damage, indicating that combined ECG and EGCG
were optimal for blocking ROS elevation and DNA damage
induced by combined NNK, B[a]P, and PhIP. Consistently, ECG
was more effective than EGCG, and a combination of ECG and
EGCG was more effective than individual catechins in suppression
of Ras expression, Erk activity, and Nox-1 expression (Figure 4A3), as well as cellular proliferation (4A-4) transiently induced by a
single exposure to NBP. These results indicate that a combination
of ECG and EGCG, at non-cytotoxic levels, was more effective
than individual agents in blocking NBP-induced transient endpoints, which are essential for induction of cellular carcinogenesis.
To verify the ability of ECG and EGCG to intervene in the
acquisition of NBP-induced cancer-associated properties, we
repeatedly exposed MCF10A cells to NBP in the absence or
presence of 20 mg/mL ECG (E), 20 mg/mL EGCG (G), or
combined 10 mg/mL ECG and 10 mg/mL EGCG (E/G) for 10
cycles, resulting in the NBP10, NBP-E10, NBP-G10, and NBP-E/
G10 cell lines, respectively. We detected that ECG was more
effective than EGCG and a combination of ECG and EGCG was
more effective than individual catechins in intervention of cellular
acquisition of RDGF (Figure 4B-1), AIG (4B-2), increased cell
migration (4B-3), invasion (4B-4), and proliferation (4B-5), as well
as ROS elevation (4B-6) and Ras-Erk-Nox pathway activation (4B7). Furthermore, NBP-increased mammosphere formation (Figure 4B-8) and ALDH-positive stem-like cell population (4B-9) as
well as EMT-associated MMP-9 induction, Vimentin induction,
EpCAM reduction, and E-cadherin reduction (4B-10) were also
blocked by co-exposure to ECG and EGCG. Consistently, ECG
was more effective than EGCG, and a combination of ECG and
EGCG was more effective than individual catechins in suppressing
these properties. These results indicated that ECG and EGCG, at
non-cytotoxic levels, were effective in suppression of breast cell
carcinogenesis associated with long-term exposure to NBP. A
combination of ECG and EGCG was more effective than either
agent alone, at equivalent doses, in suppression of NBP-induced
transient endpoints and constitutive cancer-associated properties.
However, whether non-cytotoxic ECG and EGCG are effective in
prevention of sporadic breast cancer development associated with
PLOS ONE | www.plosone.org

long-term exposure to NBP will need epidemiological and clinical
studies for validation.
Our unique model presents several advantages over others to
advance our understanding of human breast carcinogenesis and
early intervention. It is highly sensitive in detecting physiologicallyachievable, low doses of either weak or potent carcinogens capable
of inducing breast cell carcinogenesis. It takes a unique approach
of exposing cells to carcinogens in a cumulative manner for
progressive induction of chronic carcinogenesis from non-cancerous to pre-cancerous and cancerous stages. In addition, it uses
measurable transient and constitutive cellular, biochemical, and
molecular endpoints to determine the induction and progression of
cellular carcinogenesis and to identify non-cytotoxic agents
effective in intervention. In this communication, we used our
model to demonstrate, for the first time, the ability of two relatively
weak breast carcinogens, NNK and B[a]P, to enhance breast cell
carcinogenesis induced by potent breast carcinogen PhIP; we also
identified the ability of combined ECG and EGCG, which was
more effective than individual catechins, to intervene in carcinogenesis induced by combined NNK, B[a]P, and PhIP. We
reported that transient induction of ROS, the Ras-Erk-Nox
pathway, increased cell proliferation, and DNA damage accounted
for the mechanisms of initiation of cellular carcinogenesis during
each exposure to NNK, B[a]P, and/or PhIP [34,35], ultimately
leading to acquisition of cancer-associated properties and
progression of cellular carcinogenesis induced by cumulative
exposures. These transient endpoints were highly enhanced by
combined NNK, B[a]P, and PhIP. Blockage of ROS elevation or
the Ras-Erk-Nox pathway significantly reduced NBP-induced
DNA damage and cell proliferation, indicating essential roles of
ROS elevation and Ras-Erk-Nox pathway activation in NBPinduced cellular carcinogenesis. Accordingly, transient induction
of ROS elevation and the Ras-Erk-Nox pathway served not only
as markers for detecting NBP effects but also as targets for
suppressing NBP-induced carcinogenesis. As we demonstrated in
this communication, we initially used ROS elevation and the RasErk-Nox pathway as targets to detect the optimal concentration
and combination of ECG and EGCG effective in suppression of
NBP-induced transient endpoints. Subsequently, we used cancerassociated properties/constitutive endpoints as targets to verify the
effectiveness of combined ECG and EGCG in intervention of
NBP-induced progression of cellular carcinogenesis. Previously, we
reported the mitogenic ability of NNK at 100 pmol/L, B[a]P at
100 pmol/L, and PhIP at 10 nmol/L to induce increased cell
proliferation in a single exposure and after cumulative exposures
[29–36]. Here, we showed that a combination of these carcinogens
(NBP) at these same doses was also mitogenic (Figures 1B-4, 4A-4,
&4B-5). In addition, induction of reduced viability or cell death by
NBP was not detectable (data not shown), indicating that NBP was
not cytotoxic at all. Thus, like NB- or PhIP-induced carcinogenesis
progression [33–36], NBP-induced breast cell carcinogenesis did
not involve the selection of apoptosis-resistant carcinogenic clones;
instead, cumulative exposures to NBP resulted in progressive
cellular acquisition of cancer-associated properties.
In addition, our model system is able to address whether
preventive agents are effective in intervention of cancer stem-like
cell development. Development of cancer stem-like cells, involving
induction of the EMT program, has been postulated to play
8
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Figure 4. Intervention of NBP-induced carcinogenesis. (A-1 to A-4) MCF10A cells were treated with NBP in the absence and presence of ECG
(E), EGCG (G), or a combination of ECG and EGCG (E+G) for 24 h. (B-1 to B-10) MCF10A (10A) cells were exposed to NBP in the absence and presence
of 20 mg/mL ECG, 20 mg/mL EGCG, or combined 10 mg/mL ECG and 10 mg/mL EGCG (E/G) for 10 cycles, resulting in the NBP10, NBP-E10, NBP-G10,
and NBP-E/G10 cell lines, respectively. (A-1 and B-6) Relative level of ROS as fold induction (X, arbitrary unit) was normalized by the level determined
in untreated cells, set as 1. (A-2) Relative DNA damage was measured by a comet assay and normalized by the value of average tail moment
determined in untreated counterpart cells, set as 1 (X, arbitrary unit). (A-3 and B-7) Cell lysates were analyzed by immunoblotting using specific
antibodies to detect levels of H-Ras, phosphorylated-Erk1/2 (p-Erk1/2), Erk1/2, and Nox-1, with b-actin as a control, and these levels were quantified
by densitometry. Levels of H-Ras and Nox-1 were calculated by normalizing with the level of b-actin and the level set in untreated control cells as 1 (X,
arbitrary unit). Levels of specific phosphorylation of Erk1/2 (p/Erk) were calculated by normalizing the levels of p-Erk1/2 with the levels of Erk1/2, then
the level set in control cells as 1 (X, arbitrary unit). (A-4 and B-5) Relative cell proliferation was determined and normalized by the value of BrdU
detected in untreated cells, set as 100%. (B-1) To determine cellular acquisition of RDGF, cells were maintained in LM medium for 10 days. Cell
colonies $0.5 mm diameter were counted. (B-2) To determine cellular acquisition of AIG, cells were seeded in soft agar for 14 days. Cell colonies $
0.1 mm diameter were counted. (B-3) Cellular migratory and (B-4) invasive activities were determined by counting the numbers of cells translocated
through a polycarbonate filter without or with coated Matrigel, respectively, in 10 arbitrary visual fields. (B-8) To determine cellular acquisition of the
ability of serum-independent non-adherent growth (SINAG), cells were seeded in non-adherent cultures for 10 days; then, mammospheres ($0.1 mm
diameter) were counted. (B-9) Mammospheres were collected and trypsinized, and ALDH-expressing (ALDH+) cell population (%) was measured by
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flow cytometry. (B-10) Cell lysates were analyzed by immunoblotting using specific antibodies to detect levels of EpCAM, E-cadherin, MMP-9 and
Vimentin, with b-actin as a control, and these levels were quantified by densitometry. The levels of EpCAM, E-cadherin, MMP-9 and Vimentin were
calculated by normalizing with the level of b-actin and the level set in untreated control cells as 1 (X, arbitrary unit). Columns, mean of triplicates; bars,
SD. All results are representative of three independent experiments. Statistical significance is indicated by * P,0.05, ** P,0.01, and *** P,0.001.
doi:10.1371/journal.pone.0108698.g004

important roles in cancer development [37] and cancer recurrence
after chemotherapy [47]. Using our model, we demonstrated the
ability of NBP to induce increased stem-like cell population and
the EMT program in ER-negative MCF10A cells (Figures 2A–F,
4B-3, 4B-4, and 4B-8 to 4B-10). These results provide evidence for
the involvement of mesenchymal stem-like properties during the
carcinogenic transformation of ER-negative breast cells. In
addition, long-term NBP exposure resulted in acquisition of
increased cancer-associated properties by not only non-cancerous
MCF10A but also cancerous MCF7 cells in an ER-independent
manner. Possibly, long-term exposure to NBP may also result in
increased mesenchymal stem-like properties in other types of
breast cancer cells, such as basal-like, triple-negative cancer cells.
However, whether long-term exposure of triple-negative cancer
cells to NBP will result in increased carcinogenic potency remains
to be clarified. Using our model, we also demonstrated that
combined ECG and EGCG was more effective than individual
agents in intervention of NBP-increased stem-like cell population

and EMT program induction. Thus, applying our model will help
accelerate our understanding of low-dose carcinogens in breast cell
carcinogenesis and identification of preventive agents effective in
reducing the health risk of sporadic breast cancer associated with
chronic exposure to low doses of environmental and dietary
carcinogens.
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